Science and Research

Interventional Oncology Market to Reach $4.38 Billion by 2030 at CAGR 8.55% - Grand View Research, Inc.

SAN FRANCISCO, Nov. 11, 2025, 12:30 GMT-05

Grand-View-Oncology

Read full article →

Lexogen honored as one of Austria's Top Innovative Companies 2026 by Statista and trend. magazine

VIENNA, Nov. 11, 2025, 09:00 GMT-05

LEXOGEN-Statista

Read full article →

Expanse Medical Expands to Providence, Rhode Island with Support from the Rhode Island Life Science Hub

PROVIDENCE, R.I. and PLEASANTON, Calif., Nov. 11, 2025, 08:01 GMT-05

ExpanseMedical

Read full article →

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

BOSTON and SAN DIEGO, Nov. 11, 2025, 08:01 GMT-05

SOPHiA-GENETICS

Read full article →

Embodied AI Ushers in a New Robotics Era: ABI Research Identifies Multi-Billion-Dollar Retrofit Market and Even Larger Greenfield Opportunity

NEW YORK, Nov. 11, 2025, 08:00 GMT-05

ABI

Read full article →

New research from Workday Partner reveals AI disruption forcing big changes for HR consultancies

LONDON, Nov. 11, 2025, 03:56 GMT-05

Kognitiv-AI

Read full article →

Russell Reynolds Associates Names Dr. Tomas Chamorro-Premuzic as Firm's First Chief Science Officer

NEW YORK, Nov. 10, 2025, 09:06 GMT-05

Russell-Reynolds-UK

Read full article →

Six in 10 organizations expect AI to be an active team member or supervisor to other AI in the next 12 months

PARIS, Nov. 10, 2025, 01:00 GMT-05

Capgemini-AI

Read full article →

CCTV+: International Symposium on Plant Biosafety (ISPB 2025) Convenes in Guangzhou

GUANGZHOU, China, Nov. 10, 2025, 22:29 GMT-05

CCTV+

Read full article →

Clinically meaningful pivotal study results for olezarsen in sHTG presented as a late breaker at AHA Scientific Sessions

STOCKHOLM, Nov. 8, 2025, 10:40 GMT-05

SOBI-olezarsen

Read full article →

Nucleome Therapeutics founder Professor James Davies and Oxford University publish paper in prestigious journal Cell

OXFORD, England, Nov. 6, 2025, 04:00 GMT-05

Nucleome-Therapeutics

Read full article →

Abzena and Mabqi Announce Strategic Partnership to Offer Integrated Discovery through Development Solution

SAN DIEGO and MONTPELLIER, France, Nov. 6, 2025, 03:00 GMT-05

Abzena-Mabqi

Read full article →

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy

LOS ANGELES, Nov. 6, 2025, 02:00 GMT-05

LunaiBioworksTumors

Read full article →

Zifo Reports Record Customer Satisfaction Scores for Scientific Application Support and Lab Compute Services

CAMBRIDGE, Mass. and CAMBRIDGE, England and CHENNAI, India, Nov. 5, 2025, 08:00 GMT-05

ZIFO-CSAT-report

Read full article →

INTREPID Alliance Launches Antiviral Toolbox to Support Global Research Community

CAMBRIDGE, Mass., Nov. 4, 2025, 13:14 GMT-05

INTREPID-Alliance

Read full article →

MOBILion Systems to Present Transformative Advances in Proteomics Sensitivity and Throughput at HUPO 2025

CHADDS FORD, Pa., Nov. 4, 2025, 09:35 GMT-05

MOBILion-HUPO

Read full article →

Metabolon Powers Largest-Ever Veteran Metabolomics Study with Global Discovery Panel

MORRISVILLE, N.C., Nov. 4, 2025, 09:00 GMT-05

Metabolon-Inc.

Read full article →

Breakthrough Properties Completes One Helix, A Cutting-edge Research Facility Fully Leased to AstraZeneca

AMSTERDAM, Nov. 4, 2025, 09:00 GMT-05

Breakthrough-OneHelix

Read full article →

Elsevier's global survey of 3,000 researchers reveals less than half have time to do research but see AI as transformative if given right tools

LONDON, Nov. 4, 2025, 03:00 GMT-05

Elsevier-Survey

Read full article →

Naturecan Welcomes FDA NMN Ruling, Unlocking New Global Opportunities

LONDON, Nov. 3, 2025, 05:00 GMT-05

NATURECAN-NMN-FDA

Read full article →